Introduction {#s1}
============

MicroRNAs (miRNAs) represent a class of small (∼19--29 nucleotides) non coding RNAs that participate in gene post-transcriptional regulation. By binding to complementary target sites that are mainly located in gene 3\'UTR regions, miRNAs inhibit mRNA translation either via mRNA degradation or via repression of mRNA translation [@pone.0045863-Carthew1]. A complete or nearly complete match of the miRNA with its target sequence generally results in a decrease of gene expression while a mismatch lead to a repression of mRNA translation. In general, miRNAs participate in regulating the expression of genes located remote from their genomic sequence; however when miRNAs are located within gene introns they are highly likely to modulate the expression of the host gene [@pone.0045863-Rodriguez1], [@pone.0045863-Kim1].

According to the latest miRNA reference database (miRBase release 18, [www.mirbase.org](http://www.mirbase.org)) [@pone.0045863-GriffithsJones1], it is estimated that more than 1,500 miRNAs could exist in humans. A given miRNA may have several mRNA targets and participates in the regulation of a network of genes with genomic sequence similarities [@pone.0045863-Lewis1]. Reciprocally, a given mRNA may harbour in its 3\'UTR region several different miRNA target sites and then be under the control of a set of miRNAs. It is estimated that, overall, about 50% of the genome would be subject to regulation by miRNAs [@pone.0045863-Bartel1], [@pone.0045863-Krol1], making them one of the most important component of a cell. It is then not surprising to find miRNAs associated with a large number of human diseases (∼300 diseases according to the human miRNA disease database [@pone.0045863-Lu1]) including cardiovascular and metabolic disorders [@pone.0045863-Mishra1]--[@pone.0045863-Leeper1].

As with any genomic sequence, miRNAs are prone to nucleotide variations that may have non negligible effects. The presence of a single nucleotide polymorphism (SNP) in the long miRNA primary (pri-miRNA) may affect its maturation process, its expression or the binding of the mature form to its target, which would then influence the expression of the target genes [@pone.0045863-Slaby1], [@pone.0045863-Hughes1]. This is the case, for example, for rs11614913 located in the pri-miRNA-196. It is hypothesized that this SNP affects miR-196a-2 expression, alters the miRNA--target binding site and influences cancer risks [@pone.0045863-Tian1], [@pone.0045863-Hu1]. The existence of a SNP in the miRNA genomic sequence may create mature miRNA variants, named isomiRs, whose predicted targets could differ from the original miRNA\'s targets [@pone.0045863-Morin1]. In addition, the expression of miRNAs is known to be regulated by transcriptional factors, and by polymorphisms within the transcription factor binding sites, which may then modulate miRNA expression [@pone.0045863-Lin1]. Finally, the presence of a SNP in the miRNA target sequences could also influence the expression of the targeted mRNAs [@pone.0045863-Clop1], [@pone.0045863-Martin1]. As an example, the rs58186-C allele located in the 3\'UTR region of the *AGTR1* gene has been shown to decrease the efficiency of the binding of miR-155 to this gene. leading to an increase in *AGTR1* expression [@pone.0045863-Martin1].

In this study, we conducted a genome-wide investigation of the effect of pri-miRNA SNPs (miSNPs) on monocyte gene expression in a large epidemiological study of healthy subjects for whom genome-wide monocyte gene expressions and genotype data have been collected, as part of the Gutenberg Health Study [@pone.0045863-Castagne1]--[@pone.0045863-Rotival1]. We also conducted a genome-wide search for pair-wise interactions between miSNPs and SNPs located in 3\'UTR regions (3utrSNPs). We reasoned that such investigation could help to identify novel miRNA-sensitive regulation of gene expression in a key cell type participating in several disease processes including inflammation, atherosclerosis and immunity [@pone.0045863-Weber1]. miSNPs effects identified were further validated for replication in a second large monocyte expression dataset, the Cardiogenics Transcriptomic Study (CTS) [@pone.0045863-Heinig1].

Results {#s2}
=======

The Gutenberg Health Study (GHS) comprised 1,467 individuals (750 men and 717 women) [@pone.0045863-Zeller1]. All these individuals were typed for common SNPs using the Affymetrix Genome-Wide Human SNP Array 6.0 and their monocyte expression profiles were obtained from the Illumina HT-12 v3 Beadchip. Detailed description of these genome-wide expression and genotype data has already been provided elsewhere [@pone.0045863-Castagne1]--[@pone.0045863-Rotival1].

Probes and SNPs selection {#s2a}
-------------------------

The GRCH37 release of the Human reference genome and the 17^th^ release of the miRNA database [@pone.0045863-GriffithsJones1] were used to identify SNPs located within pri-miRNA sequences and 3\'UTR regions. The number of miSNPs genotyped in GHS, or that could be substituted according to the SNAP software [@pone.0045863-Johnson1] by a "proxy" genotyped SNP in strong correlation (when expressed in terms of a pairwise linkage disequilibrium (LD) r^2^greater than 0.90) was 294, representing 258 distinct miRNAs.

The pre-processing of the expression data (see Methods) identified 22,004 probes covering 15,786 genes of "perfect" quality score according to ReMOAT [@pone.0045863-BarbosaMorais1] and not harboring a SNP in their genomic sequence. These probes were then tested for association with all genotyped miSNPs.

The search for interactions between miSNPs and 3utrSNP was restricted to probes targeting genes known to contain SNPs in their 3\'UTR region that were either directly genotyped in GHS, or tagged by genotyped SNPs (r^2^\>0.90). This led to the selection of a subsample of 8,768 probes characterizing 6,147 genes. In these genes, the total number of 3utrSNPs (or "proxy") that were further studied was 10,783. The distribution of the number of 3utrSNPs per gene is given in [Table 1](#pone-0045863-t001){ref-type="table"}.

10.1371/journal.pone.0045863.t001

###### Distribution of the number of 3utrSNPs (or proxy) in the 6,147 studied genes.

![](pone.0045863.t001){#pone-0045863-t001-1}

  --------------------- ------- ------- ----- ----- ----- ---- ---- ---- --- ---- ---- ---- ---- ---- ----
  \# 3utrSNPsper gene      1       2      3     4     5    6    7    8    9   10   11   12   13   14   18
  \# genes               3,435   1,438   670   313   138   80   35   17   7   4    5    1    1    2    1
  --------------------- ------- ------- ----- ----- ----- ---- ---- ---- --- ---- ---- ---- ---- ---- ----

Note that, in some instances, a genotyped SNP can serve as a proxy (r^2^ \>0.90) for several 3utr SNPs. This explains why the total number of 3utr proxy SNPs that can be derived from this table (11,353  =  1×3,435 + 2×1,438 + 3\*670 + \.....) is slightly higher than the number of really studied SNPs (10,783).

Association of miSNPs with gene expression {#s2b}
------------------------------------------

### GHS discovery phase {#s2b1}

This analysis can be viewed as an ancillary study of the whole genome-wide association study between all genotyped SNPs and all expressions already conducted in GHS and whose results can be found in a publicly available resource [@pone.0045863-Zeller1]. At the Bonferroni correction level of 7.73×10^−9^ (ie. 0.05/(294×22,004)), fifty-seven associations between miSNPs and gene expression were significant ([Table S1](#pone.0045863.s001){ref-type="supplementary-material"}). However, forty-eight of these associations implicated miSNPs proxies mapping the genomic region of the genes they were associated with. We interrogated the GHS express database to identify the SNPs showing the strongest association with the associated expression among those with p\<5.50×10^−5^ and located within 1Mb of the probe genomic sequence, thereafter referred to as the best *cis* eSNPs [@pone.0045863-Zeller1]. In six cases, the miSNP proxies were the best *cis* eSNPs. After adjusting for the effect of the best *cis* eSNPs, most miSNPs association vanished and only seven (bold lines in [Table S1](#pone.0045863.s001){ref-type="supplementary-material"}) remained significant at p = 7.73×10^−9^. Most of these 48 *cis* miSNPs associations are then likely due to LD between miSNPs and "true" *cis* eSNPs. Nevertheless, this must be investigated in greater depth as in several examples the corresponding miRNA was located within an intron of the associated gene, and could therefore participate in the regulation of the host gene.

Of more interest are the nine genome-wide significant associations that involved a miSNP located on a chromosome distinct from the one mapped by the associated gene, so called *trans* associations referring to associations involving SNPs that are located more than 1Mb away, or a distinct chromosome, from the associated probe. As shown in [Table 2](#pone-0045863-t002){ref-type="table"}, the hsa-mir-1279 SNP rs1463335, tagged by the SNP rs317657 (r^2^ = 1.0), was associated in *cis* with expression of *LYZ* (R^2^ = 20.1%; p = 1.36×10^−76^) and *YEATS4* (R^2^ = 13.1%; p = 1.32×10^−46^), and in *trans* with expression of *CNTN6* (R^2^ = 3.3%; p = 1.16×10^−12^), *CTRC* (R^2^ = 3.5%; p = 1.39×10^−13^), *COPZ2* (R^2^ = 3.0%; p = 2.33×10^−11^), *KRT9* (R^2^ = 4.5%; p = 1.15×10^−15^), *LRRFIP1* (R^2^ = 10.0%; p = 1.50×10^−35^), *NOD1* (R^2^ = 2.1%; p = 7.25×10^−9^), *PCDHA6* (R^2^ = 9.2%; p = 9.44×10^−33^), *ST5* (R^2^ = 5.1%; p = 2.05×10^−18^) and *TRAF3IP2* (R^2^ = 4.9%; p = 2.74×10^−17^). It is of note that whereas the rs317657-C allele, with minor allele frequency 0.46, was associated with increased expression of *LYZ*, *YEATS4* and *NOD1*, it was associated with decreased levels of *CNTN6, CTRC, COPZ2, KRT9, LRRFIP1, PCDHA6, ST5* and *TRAF3IP2* expression. After adjusting for the best *LYZ cis* eSNP, the association of rs317657 with *LYZ* expression still retained genome-wide significance (p = 6.17×10^−11^) while the association with *YEATS4* disappeared (p = 0.734) ([Table S1](#pone.0045863.s001){ref-type="supplementary-material"}). According to the TargetScan bioinformatics tool [@pone.0045863-Lewis1], the position 648 to 654 of the 3\'UTR *LYZ* region is predicted to be complementary at 8 bases with the hsa-mir-1279 sequence. This type of matching configuration, called 8mer, is usually considered to be a good prior for predicting potential targets of miRNA. After adjusting for *LYZ* expression, the *trans* association observed with rs317657 were reduced, but remained highly significant, p = 3.88×10^−11^, p = 1.15×10^−7^, p = 2.52×10^−6^, p = 1.65×10^−10^, p = 7.16×10^−29^, p = 2.44×10^−5^, p = 8.23×10^−28^, p = 1.81×10^−13^, p = 5.66×10^−10^ for *CNTN6*, *CTRC*, *COPZ2*, *KRT9*, *LRRFIP1*, *NOD1*, *PCDHA6*, *ST5* and *TRAF3IP2*, respectively. Corresponding p-values for the *trans* associations adjusted for *YEATS4* expression were p = 1.86×10^−9^, p = 1.72×10^−11^, p = 6.45×10^−9^, p = 9.48×10^−12^, p = 6.10×10^−28^, p = 3.76×10^−13^, p = 1.59×10^−28^, p = 2.33×10^−13^, p = 5.10×10^−8^, respectively. When the *trans* associations were adjusted for both *LYZ* and *YEATS4* expressions, they were hardly modified, with p-values ranging between p = 2.98×10^−6^ (*COPZ2*) to p = 6.55×10^−27^ (*PCDHA6*). As indicated in [Table 3](#pone-0045863-t003){ref-type="table"}, these nine genes were not strongly correlated with each other, nor with expression of LYZ, the gene in which the rs31757 SNP was located.

10.1371/journal.pone.0045863.t002

###### *Cis* and *trans*-associations observed with the hsa-mir-1279 rs1463335[(1)](#nt102){ref-type="table-fn"}.
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  Associated Gene Expression                      GHS                      CTS                                                                         
  ---------------------------- ------------------------------------------ ----- ----------- ----------- ------- ------- -------------- ------- ------- --------------
  ILMN_1748730                                    CTRC                      1    15764937    15773152    −0.03   0.004   1.39 10^−13^   −0.06   0.007   1.54 10^−15^
  ILMN_2252021                                  LRRFIP1                     2    238536223   238690289   −0.05   0.004   1.50 10^−35^   −0.12   0.010   6.65 10^−32^
  ILMN_1699317                                   CNTN6                      3     1134628     1445277    −0.02   0.003   1.16 10^−12^   −0.04   0.006   7.56 10^−12^
  ILMN_1740494                                   PCDHA6                     5    140207649   140391928   −0.04   0.003   9.44 10^−33^   −0.10   0.008   2.67 10^−31^
  ILMN_1663381                                  TRAF3IP2                    6    111880142   111927320   −0.03   0.003   2.74 10^−17^   −0.06   0.007   5.23 10^−17^
  ILMN_2114422                                    NOD1                      7    30464142    30518392    0.05    0.008   7.25 10^−9^    0.12    0.013   7.83 10^−19^
  ILMN_1731063                                    ST5                      11     8714898     8932497    −0.06   0.007   2.05 10^−18^   −0.22   0.019   2.51 10^−30^
  ILMN_1815205                   LYZ[(1)](#nt102){ref-type="table-fn"}     12    69742133    69748012    0.20    0.010   1.36 10^−76^    NA      NA          NA
  ILMN_1801387                  YEATS4[(1)](#nt102){ref-type="table-fn"}   12    69753531    69784575    0.15    0.010   1.32 10^−46^   0.19    0.020   3.27 10^−21^
  ILMN_1792568                                    KRT9                     17    39722092    39728309    −0.04   0.006   1.15 10^−15^   −0.11   0.016   1.11 10^−11^
  ILMN_1667361                                   COPZ2                     17    46103532    46115151    −0.03   0.005   2.33 10^−11^   −0.10   0.011   2.06 10^−18^

The rs1463335 was tagged by the rs317657 and rs998022 in GHS and CTS, respectively. The rs146335 is located on chromosome 12, at position 69,667,075. As a consequence, the association observed with LYZ and YEATS4 are considered as *cis*-associations, the remaining eight as trans-associations.

Regression coefficient associated with the rare miSNP allele under an additive effect model, adjusted for age and gender

P-value of the association between miSNP and gene expression

10.1371/journal.pone.0045863.t003

###### Correlation between gene expressions influenced by the rs317657 tagging the hsa-mir-1279 rs1463335.
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               CTRC    LRRFIP1   CNTN6    PCDHA6   TRAF3IP2    NOD1     ST5      LYZ     YEATS4   KRT9
  ---------- -------- --------- -------- -------- ---------- -------- -------- -------- -------- -------
  LRRFIP1     0.204       1                                                                      
  CNTN6       0.137     0.237      1                                                             
  PCDHA6      0.202     0.449    0.200      1                                                    
  TRAF3IP2    0.129     0.271    0.202    0.270       1                                          
  NOD1        0.225    −0.126    0.047    −0.062    0.029       1                                
  ST5         0.210     0.517    0.192    0.411     0.274     −0.176     1                       
  LYZ         −0.156   −0.143    −0.070   −0.125    −0.170    0.113    −0.125     1              
  YEATS4      −0.079   −0.162    −0.110   −0.113    −0.250    −0.070   −0.140   0.558      1     
  KRT9        0.217     0.485    0.168    0.402     0.302     −0.166   0.740    −0.133   −0.121     1
  COPZ2       0.188     0.400    0.131    0.341     0.236     −0.140   0.592    −0.143   −0.093   0.590

### Replication in CTS {#s2b2}

We focused on the genome-wide significant *trans* associations observed with the hsa-mir-1279 miSNP proxy. These associations were tested for replication in CTS where monocyte expression was measured in a sample of 395 healthy individuals and 363 patients with coronary artery disease [@pone.0045863-Heinig1]. In CTS, the hsa-mir-1279 rs1463335 proxy was the rs998022 (r^2^ = 0.90). Its pairwise r^2^ with the GHS rs317657 proxy was 0.84. The probe tagging the *LYZ* gene expression was not available in CTS, but all other associations were replicable. As indicated in [Table 2](#pone-0045863-t002){ref-type="table"}, they all replicated with consistent pattern of association as in GHS. The rs998022-G allele tagging the rs317657-C allele was associated with increased expression of *YEATS4* (R^2^ = 11.2%; p = 3.21×10^−21^) and *NOD1* (R^2^ = 9.82%; p = 7.83×10^−19^), but with decreased expression of *CNTN6* (R^2^ = 5.9%; p = 7.56×10^−12^), *CTRC* (R^2^ = 8.1%; p = 1.54×10^−15^), *COPZ2* (R^2^ = 9.7%; p = 2.06×10^−18^), *KRT9* (R^2^ = 5.9%; p = 1.11×10^−11^), *LRRFIP1* (R^2^ = 16.7%; p = 6.65×10^−32^), *PCDHA6* (R^2^ = 16.4%; p = 2.67×10^−31^), *ST5* (R^2^ = 17.0%; p = 2.51×10^−30^) and *TRAF3IP2* (R^2^ = 8.9%; p = 5.23×10^−17^). Associations were homogeneously observed in CAD patients and healthy subjects from CTS ([Table S2](#pone.0045863.s002){ref-type="supplementary-material"}).

Search for miSNP × 3utrSNP interactions {#s2c}
---------------------------------------

### GHS discovery phase {#s2c1}

Each 3utrSNP was tested for interaction with all miSNPs with respect to the expression levels of the probes tagging the 3utrSNP-associated gene. Interactions were assessed using a standard linear regression analysis where both SNPs coded as 0,1,2 were included to the model together with the corresponding interaction term. Analyses were adjusted for age and sex. The total number of tested interactions was 4,890,102.

Instead of applying the standard Bonferroni correction to handle multiple testing, we followed the suggestion by Pare et al. [@pone.0045863-Pare1] and adopted a weighted-Bonferroni correction according to the p-value of the Levene\'s test. This consists in prioritizing 3utrSNPs according to the significance of the test for a difference in the variance of expressions according to genotypes. This strategy relies on the statistical property that a significant difference in phenotypic variances according to sub-groups could be a marker for interaction phenomena.

Using this weighted-Bonferroni correction, 51 miSNP × 3utrSNP interactions were genome-wide significant at p\<1.02×10^−8^ ([Table 4](#pone-0045863-t004){ref-type="table"}). Note, only 31 would have been declared significant according the standard Bonferroni procedure ([Table 4](#pone-0045863-t004){ref-type="table"}). Seventeen of the detected interactions involved the *RFPL1* rs13053624 that was found to interact with 17 miSNPs over 16 distinct miRNAs to modulate *RFPL1* expression (probe ILMN_1797383). One of these interacting miRNAs was hsa-mir-3674. Interestingly, according to microSNiPer database [@pone.0045863-Barenboim1], *RFPL1* is predicted to harbor a SNP, rs13053817, in a potential target site for hsa-mir-3674 that is, according to the SNAP database, in nearly complete association with the identified rs13053624 (r^2^ = 0.90). No other strong biological and bioinformatics evidence could be obtained from public databases (miRanda [@pone.0045863-John1], TargetScan [@pone.0045863-Lewis1], DianaMicro [@pone.0045863-Maragkakis1], PicTar [@pone.0045863-Krek1], mirBase [@pone.0045863-GriffithsJones1]) in favour of the 30 other genes we identified through our interaction search ([Table 4](#pone-0045863-t004){ref-type="table"}).

10.1371/journal.pone.0045863.t004

###### Genome-wide significant (p\<1.02 10^−8^) interactions between miSNPs and 3utrSNPs on monocyte gene expression in the Gutenberg Health Study.
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                                                                                     GHS                                                  
  ---------- ---- -------------- ------------ ---------------- ---- ------------ ------------ ------------ -------------- --------------- --------------
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-592     7    rs11563750   rs11563505   rs13053817   1.04 10^−35^    3.22 10^−5^    1.50 10^−36^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-3920    11   rs12275715   rs12283329   rs13053817   1.21 10^−26^    3.22 10^−5^    1.74 10^−27^
  TXNDC5      6    ILMN_1769082     rs8643     hsa-mir-125b-2   21   rs2823897    rs2211981      rs8643     8.95 10^−18^    3.39 10^−1^    1.23 10^−17^
  TXNDC5      6    ILMN_1769082   rs1043784    hsa-mir-125b-2   21   rs2823897    rs2211981    rs3734589    1.26 10^−17^    3.18 10^−1^    1.64 10^−17^
  LYZ         12   ILMN_1815205    rs710794     hsa-mir-1279    12   rs1463335     rs317657     rs710794    4.13 10^−15^   4.51 10^−23^    1.20 10^−16^
  ASB1        2    ILMN_1683096   rs1044561    hsa-mir-125b-2   21   rs2823897    rs2211981    rs2334004    1.45 10^−16^    8.91 10^−1^    1.87 10^−15^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-4656    7    rs3750013    rs17135110   rs13053817   2.28 10^−14^    3.22 10^−5^    3.29 10^−15^
  ASB1        2    ILMN_1683096   rs2278768    hsa-mir-3119-1   1    rs17349873   rs1330387    rs2278768    3.71 10^−14^    1.34 10^−6^    4.10 10^−15^
  RFPL1       22   ILMN_1797383   rs13053624   hsa-mir-30c-1    1    rs16827546   rs16827546   rs13053817   2.89 10^−14^    3.22 10^−5^    4.16 10^−15^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-1307    10   rs7911488    rs2271751    rs9287035    2.98 10^−13^   9.07 10^−46^    4.29 10^−15^
  RFPL1       22   ILMN_1797383   rs13053624   hsa-mir-125b-1   11   rs2081443    rs2081443    rs13053817   2.40 10^−13^    3.22 10^−5^    3.47 10^−14^
  PKD1L2      16   ILMN_1742788   rs1901818     hsa-mir-4272    3    rs9868022    rs9868022    rs7198127    8.92 10^−14^    8.80 10^−2^    5.47 10^−14^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-4670    9    rs2104533    rs2296666    rs9287035    5.16 10^−12^   9.07 10^−46^    7.42 10^−14^
  ASB1        2    ILMN_1683096   rs2278768    hsa-mir-125b-2   21   rs2823897    rs2211981    rs2278768    5.30 10^−12^    1.34 10^−6^    5.85 10^−12^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-4300    11   rs11603185   rs7944477    rs13053817   2.02 10^−11^    3.22 10^−5^    2.92 10^−12^
  SPRY1       4    ILMN_2329914    rs300574     hsa-mir-4666    1    rs16841344   rs4653963     rs300555    1.52 10^−11^    1.16 10^−2^    5.10 10^−12^
  HLA-DPB1    6    ILMN_1749070   rs1042448    hsa-mir-219-1    6     rs107822     rs213208    rs3128923    1.26 10^−10^    4.11 10^−8^    1.11 10^−11^
  ASB1        2    ILMN_1683096   rs2278768     hsa-mir-4636    5     rs257095    rs6555591    rs2278768    1.09 10^−10^    1.34 10^−6^    1.20 10^−11^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-4292    9    rs2811749    rs2811749    rs13053817   1.98 10^−10^    3.22 10^−5^    2.86 10^−11^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-624     14   rs11156654   rs11156654   rs13053817   2.20 10^−10^    3.22 10^−5^    3.18 10^−11^
  GPRC5C      17   ILMN_1724211   rs2706527     hsa-mir-3667    22    rs135771     rs135775    rs2706526    5.46 10^−9^    5.08 10^−79^    4.52 10^−11^
  H1F0        22   ILMN_1757467   rs1894644     hsa-mir-659     22   rs5750504    rs2899293     rs763137    2.98 10^−10^    1.30 10^−1^    2.18 10^−10^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-548n    7    rs1649215    rs1637670    rs9287035    1.64 10^−8^    9.07 10^−46^    2.37 10^−10^
  RFPL1       22   ILMN_1797383   rs13053624   hsa-mir-521-1    19   rs4803178    rs4803178    rs13053817   2.88 10^−9^     3.22 10^−5^    4.16 10^−10^
  GPRC5C      17   ILMN_2352090   rs2706527     hsa-mir-3667    22    rs135771     rs135775    rs2706526    1.06 10^−7^    6.63 10^−102^   6.80 10^−10^
  GPRC5C      17   ILMN_2352090   rs2706527     hsa-mir-107     10   rs17481096   rs17481096   rs2706526    1.20 10^−7^    6.63 10^−102^   7.69 10^−10^
  HLA-DPB1    6    ILMN_1749070   rs1042448    hsa-mir-219-1    6     rs213210     rs213210    rs3128923    8.98 10^−9^     4.11 10^−8^    7.88 10^−10^
  MXRA7       17   ILMN_1743836    rs10473      hsa-mir-490     7    rs6963819    rs2350780    rs7221855    2.66 10^−7^    6.10 10^−167^   1.04 10^−9^
  SPRY1       4    ILMN_1651610    rs300574     hsa-mir-4666    1    rs16841344   rs4653963     rs300555    3.82 10^−9^     6.28 10^−3^    1.12 10^−9^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-1236    6     rs403569     rs550513    rs13053817   7.89 10^−9^     3.22 10^−5^    1.14 10^−9^
  GPRC5C      17   ILMN_2352090   rs2706527    hsa-mir-941-1    20   rs2427555    rs2427554    rs2706526    2.03 10^−7^    6.63 10^−102^   1.30 10^−9^
  POGZ        1    ILMN_2329309   rs3811409     hsa-mir-4666    1    rs16841344   rs4653963    rs3811409    2.24 10^−9^     1.12 10^−1^    1.53 10^−9^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-4643    6    rs16884450   rs16884450   rs13053817   1.28 10^−8^     3.22 10^−5^    1.85 10^−9^
  ASB1        2    ILMN_1683096   rs1044561     hsa-mir-3973    11    rs262404    rs16928224   rs2334004    1.60 10^−10^    8.91 10^−1^    2.06 10^−9^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-3646    20   rs11574730   rs11574730   rs13053817   1.70 10^−8^     3.22 10^−5^    2.45 10^−9^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-4460    5    rs13171514   rs13171514   rs9287035    2.47 10^−7^    9.07 10^−46^    3.55 10^−9^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-3674    8    rs7003112    rs6558541    rs13053817   2.55 10^−8^     3.22 10^−5^    3.67 10^−9^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-1205    8    rs9649959    rs9649959    rs13053817   2.78 10^−8^     3.22 10^−5^    4.02 10^−9^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-4656    7    rs17829969   rs17829969   rs13053817   2.82 10^−8^     3.22 10^−5^    4.07 10^−9^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-4784    2    rs6709245    rs12463867   rs9287035    3.22 10^−7^    9.07 10^−46^    4.63 10^−9^
  AAK1        2    ILMN_1880387   rs13427243    hsa-mir-3667    22    rs135771     rs135775    rs13427243   7.28 10^−9^     1.04 10^−1^    4.80 10^−9^
  RFPL1       22   ILMN_1797383   rs13053624    hsa-mir-604     10   rs2368392    rs3758371    rs13053817   3.69 10^−8^     3.22 10^−5^    5.32 10^−9^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-215     1    rs3820455    rs34406824   rs9287035    3.88 10^−7^    9.07 10^−46^    5.58 10^−9^
  RBM12       20   ILMN_1670841   rs6060539     hsa-mir-4755    20   rs2284385    rs2284390    rs2425125    4.06 10^−7^    1.65 10^−47^    5.62 10^−9^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-2113    6    rs9375085    rs9375085    rs9287035    4.02 10^−7^    9.07 10^−46^    5.79 10^−9^
  RFPL1       22   ILMN_1797383   rs13053624   hsa-mir-1269b    17   rs7210937    rs2240567    rs13053817   4.93 10^−8^     3.22 10^−5^    7.10 10^−9^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-4705    13   rs7337292    rs7337292    rs9287035    5.10 10^−7^    9.07 10^−46^    7.33 10^−9^
  PKD1L2      16   ILMN_1742788   rs1901818     hsa-mir-4473    9    rs16938058   rs16938057   rs7198127    1.24 10^−8^     8.80 10^−2^    7.60 10^−9^
  MRPL43      10   ILMN_1678974   rs2295716     hsa-mir-608     10   rs4919510    rs4919510    rs3824783    3.06 10^−7^    9.68 10^−22^    9.44 10^−9^
  ECE1        1    ILMN_1672174   rs3026907     hsa-mir-520d    19   rs2217653    rs9304754    rs9287035    6.62 10^−7^    9.07 10^−46^    9.52 10^−9^
  ASB1        2    ILMN_1683096   rs1044561     hsa-mir-4636    5     rs257095    rs6555591    rs2334004    7.57 10^−10^    8.91 10^−1^    9.74 10^−9^

\(1\) P-value of the interaction test derived from the standard linear regression analysis

\(2\) P-value of the interaction test obtained when the Levene test p-value was used under a weighted-Bonferroni framework.

### Replication in CTS {#s2c2}

The fifty-one genome-wide significant interactions were tested for replication in CTS. However, only eight interactions could be replicable, which did not include the aforementioned interaction involving *RFPL1* rs13053624.

Using the same linear regression model, further adjusted for disease status as for the discovery phase, two interactions replicated in CTS at the Bonferroni-corrected level of 6.25×10^−3^ ([Table 5](#pone-0045863-t005){ref-type="table"}).

10.1371/journal.pone.0045863.t005

###### Replication in Cardiogenics of the miSNPs × 3utrSNPs detected in Gutenberg Health Study.

![](pone.0045863.t005){#pone-0045863-t005-5}

  MiSNP×3utrSNP                        rs17349873rs2278768   rs107822rs1042448   rs257095rs2278768    rs5750504rs1894644    rs6963819rs10473     rs262404rs1044561    rs2284385rs6060539   rs257095rs1044561
  ----------------------------------- --------------------- ------------------- -------------------- -------------------- -------------------- --------------------- -------------------- --------------------
  miRNA(CHR)                            hsa-mir-3119-1(1)    hsa-mir-219-1(6)     hsa-mir-4636(5)      hsa-mir-659(22)       hsa-mir-490(7)      hsa-mir-3973(11)      hsa-mir-4755(20)     hsa-mir-4636(5)
  Gene(CHR)                                  ASB1(2)            HLA-DPB1(6)           ASB1(2)              H1F0(22)             MXRA7(7)              ASB1(2)             RBM12(20)             ASB1(2)
  Probe                                   ILMN_1683096         ILMN_1749070         ILMN_1683096         ILMN_1757467         ILMN_1743836         ILMN_1683096          ILMN_1670841         ILMN_1683096
  Gutenberg Health Study                                                                                                                                                                  
  Proxies                              rs1330387rs2278768    rs213208rs3128923   rs6555591rs2278768   rs2899293rs763137    rs2350780rs7221855   rs16928224rs2334004   rs2284390rs2425125   rs6555591rs2334004
  β^(1)^                                     −0.480               −0.165               −0.233               −0.194               −0.065                0.988                0.164                0.375
  WeightedP-value ^(2)^                   4.10 10^−15^         1.11 10^−11^         1.20 10^−11^         2.18 10^−10^         1.04 10^−9^           2.06 10^−9^          5.62 10^−9^          9.74 10^−9^
  Cardiogenics Transcriptomic Study                                                                                                                                                       
  Proxies                              rs6703198rs10084192   rs439205rs3117222   rs257095rs10084192   rs6000905rs1894644   rs2350780rs9910052   rs262407rs10084192    rs2038123rs6121015   rs257095rs10084192
  β^(1)^                                      0.093               −0.274               0.045                −0.268               0.011                −0.025                0.099                0.045
  P-value ^(3)^                            4.62 10^−1^       **2.03 10^−13^**       5.18 10^−1^        **1.37 10^−8^**        5.98 10^−1^           8.29 10^−1^          7.22 10^−2^          5.18 10^−1^

\(1\) Regression coefficient of the interaction term when both miSNP and 3utr proxy SNPs coded 0/1/2 according to the number of carried rare alleles are introduced in a linear regression model together with their interaction term.

\(2\) P-value of the interaction test obtained in GHS when the Levene test p-value was used under a weighted-Bonferroni framework.

\(3\) P-value of the interaction test derived from the standard linear regression analysis in Cardiogenics. Bold p-values are significant after Bonferroni correction.

The first replicated interaction involved the *HLA-DPB1* rs1042448 and hsa-mir-219-1 rs107822 tagged by the rs3128923/rs213208 and rs3117222/rs439205 pairs in GHS and CTS, respectively. These two loci are distant from about 100 kb and the corresponding tag SNPs were in modest linkage disequilibrium (LD), r^2^ = 0.58 and r^2^ = 0.56, in GHS and CTS, respectively. In GHS, the haplotype analysis of the rs107822 and rs1042448 proxies revealed that the *HLA-DPB1* rs1042448-A proxy allele (i.e the allele at the proxy SNP that can be used to tag the rs1042448-A allele) was associated with a strong increase in *HLA-DBP1* expression (β = +0.61, p = 1.64×10^−105^) when carried on the same haplotype as the hsa-mir-219-1 rs107822-C proxy allele ([Figure 1](#pone-0045863-g001){ref-type="fig"}). Conversely, when associated with the hsa-mir-219-1 rs107822-T proxy allele, the increasing effect of the *HLA-DPB1* rs1042448-A proxy allele was significantly reduced (p = 1.88×10^−20^) and became β = +0.18 (p = 3.49×10^−8^) illustrating the interaction phenomenon identified through linear regression analysis. This interaction remained significant (p = 2.81×10^−12^) when the haplotype analysis was further adjusted on the best *cis* eSNP observed for *HLA-DBP1* expression, rs3128963 (p = 2.30×10^−151^) (see GHS_Express database [@pone.0045863-Zeller1]). The same pattern of associations was observed in CTS ([Figure 1](#pone-0045863-g001){ref-type="fig"}). The *HLA-DPB1* rs1042448-A proxy allele was associated with a strong significant increase in *HLA-DPB1* expression (β = +0.63, p = 5.24×10^−62^) when carried on the same haplotype as the hsa-mir-219-1 rs107822-C proxy allele. The corresponding increase when the rs1042248-A proxy allele was associated with the hsa-mir-219-1 rs107822-A proxy allele was significantly reduced (p = 2.68×10^−20^) and did no longer reach significance (β = +0.05; p = 0.23) ([Figure 1](#pone-0045863-g001){ref-type="fig"}).

![*HLA-DPB1* rs1042448 × *hsa-mir-219-1* rs107822 interaction on *HLA-DPB1* monocyte expression.\
In the Gutenberg Health Study, the rs1042248/rs107822 pair was tagged by rs3128923/rs213208. In the Cardiogenics Transcriptomic Study, the corresponding tagging pair was rs3117222/rs439205.](pone.0045863.g001){#pone-0045863-g001}

The second replicated interaction involved the *H1F0* rs1894644 and hsa-mir-659 rs5750504 tagged by the rs763137/rs2899293 and rs1894644/rs6000905 pairs in GHS and CTS, respectively ([Figure 2](#pone-0045863-g002){ref-type="fig"}). These two loci are distant from about 40 kb and the corresponding tag SNPs were in low LD, r^2^ = 0.15 and r^2^ = 0.14, in GHS and CTS, respectively. In GHS and in CTS, the *H1F0* rs1894644-T proxy allele was associated with a strong increase in *H1F0* expression (β = +0.65, p = 1.71×10^−53^ and β = +0.79, p = 1.36×10^−40^, respectively) when it was on the same haplotype as the rs5750504-T proxy allele. Conversely, when the rs1894644-T proxy allele was on the same haplotype as the rs5750504-A proxy allele, the corresponding increase in *H1F0* expression was lower (β = +0.23, p = 9.74×10^−13^ and β = +0.26, p = 7.25×10^−8^, respectively). The test for homogeneity of the *H1F0* rs1894644 effect according to the rs5750504 proxy was significant p = 3.03×10^−12^ and p = 5.67×10^−10^ in GHS and CTS, respectively, validating the interaction detected through standard linear regression analysis (p = 2.98×10^−10^ and p = 1.37×10^−8^, respectively). Note that, in GHS, the rs763137 SNP involved in this interaction was the best *cis* eSNP for *H1F0* (p = 1.10×10^−62^).

![*H1F0* rs1894644 × *hsa-mir-659* rs5750504 interaction on *H1F0* monocyte expression.\
In the Gutenberg Health Study, the rs1894644/rs5750504 pair was tagged by rs763137/rs2899293. In the Cardiogenics Transcriptomic Study, the corresponding tagging pair was rs1894644/rs6000905.](pone.0045863.g002){#pone-0045863-g002}

As shown in [Table S3](#pone.0045863.s003){ref-type="supplementary-material"}, the two replicated interactions were consistent in CAD and healthy subjects composing CTS.

Discussion {#s3}
==========

Coupling genome-wide association and expression studies have been an attractive strategy to disentangle the architecture of the genetics of gene expression and to assess whether gene expression dysregulation could mediate the effect of SNPs on disease risk identified through genome-wide association studies [@pone.0045863-Zeller1], [@pone.0045863-Stranger1]. To our knowledge, such studies [@pone.0045863-Zeller1], [@pone.0045863-Stranger1]--[@pone.0045863-Goring1] mainly focused on assessing marginal associations of single SNPs with gene expression. Even if SNP × SNP interactions have often been advocated as a potential source of phenotype variability [@pone.0045863-Cordell1], [@pone.0045863-Sivakumaran1], there has been few attempt to assess at the genome-wide scale whether such SNP × SNP interactions could influence gene expression variability. This is likely due to the statistical and computing burdens associated with such investigations characterized by a huge number of tested interactions and the very large sample size required to detect genome-wide significance. We postulated that focusing on plausible "biological" interactions could be one strategy to dig into the complex architecture of SNP × SNP interactions. This is why we undertook what we think is the first systematic and comprehensive search for interactions between SNPs located in the genomic sequence of miRNAs and SNPs located in the 3\'UTR gene regions that could participate in monocyte gene expression. This search for interactions was preceded by a genome-wide investigation of miSNPs effect on monocyte expression to assess whether miSNPs could influence gene expression, in particular, through *trans* regulation.

These investigations were conducted in the Gutenberg Health Study where the extensive genome-wide study of marginal SNP associations with monocyte expressions had previously been reported and the results stored in a publicly available resource [@pone.0045863-Zeller1], and we replicated the significant findings in the Cardiogenics study.

Our survey of marginal miSNP effect has pointed out the hsa-mir-1279 miRNA mapping to chromosome 12q15 as a candidate regulator of 10 genes in monocytes. Indeed, we observed that the hsa-mir-1279 rs1463335 tagged by rs317657 or rs1463335 was robustly associated in *cis* with *LYZ* expression and in *trans* with *CNTN6*, *CTRC, COPZ2*, *KRT9*, *LRRFIP1*, *NOD1*, *PCDHA6*, *ST5* and *TRAF3IP2*. The bioinformatics prediction of the *LYZ* gene as a target for hsa-mir-1279 miRNA supports this hypothesis. The lack of strong correlation between the expression of these 10 genes, together with the *trans* association observed after adjusting for *LYZ* expression, could suggest that these nine genes could also be targets for the hsa-mir-1279, despite the absence of such prediction by current bioinformatics tools. However, the observation of positive associations with *LYZ* and *NOD1*, but of negative associations with the other genes, is puzzling as we could have expected, at first sight, a similar pattern of associations if all these genes were target for hsa-mir-1279. Functional experimental work is needed to characterize the role of hsa-mir-1279 in the regulation of these genes in-depth, in particular *TRAF3IP2* as this gene was identified in two independent GWAS as a susceptibility locus for psoriasis [@pone.0045863-Ellinghaus1], [@pone.0045863-Strange1]. Our results, if confirmed, could open therapeutics perspectives as it is possible to use artificial miRNA targets to modify gene expression [@pone.0045863-Brown1], [@pone.0045863-Rayner1]. A *trans* association pattern was also recently observed at the locus 12q15 using an unsupervised gene networks analysis of the same datasets [@pone.0045863-Rotival1]. The rs11177644 located in the 3\'UTR region of the *YEATS*4 gene was also found associated in *cis* to *LYZ* and *YEATS4* and in *trans* with a module of 36 genes including the *CNTN6*, *CTRC, COPZ2*, *KRT9*, *LRRFIP1*, *NOD1* and *ST5* discussed above. However, unlike what we observed here with hsa-mir-1279 rs1463335, the *trans* associations with rs11177644 had been found mediated by *cis* regulation mechanisms. Using a standard linear regression analysis (see above), we then tested whether these two SNPs could interact to contribute to the identified *trans* associations. We did not observe any strong evidence for such phenomenon as the lowest p-value for interaction was p = 8.53×10^−4^ for *PCDHA6* (data not shown). As the rs11177644 and rs1463335 were in moderate LD (r^2^ = 0.30 and D\' = +0.70), we further conducted an haplotype analysis of the two SNPs ([Table 6](#pone-0045863-t006){ref-type="table"}). This revealed that both SNPs acted additively on *LYZ* expression but, after adjusting for rs11177644, the association of rs1463335 with *YEATS4* was no longer significant (p = 0.748). This haplotype analysis also revealed strong *trans* haplotype associations, which were due to a single haplotype, (rs317657_C/rs11177644_A), which was, after adjusting for *LYZ* and *YEATS4* expression, strongly associated with increased levels of *NOD1* (p = 8.30×10^−13^), and decreased levels of the eight other genes, with p-values ranging from 2.21×10^−6^ to 2.52×10^−38^ ([Table 6](#pone-0045863-t006){ref-type="table"}). These results suggest that the associations observed at the 12q15 locus are much more complex as initially hypothesized. It appeared that *YEATS4* and *LYZ* expressions could be under the influence of a common *cis* eSNP, but the latter would also be additionally influenced by a miSNP contributing to *trans* associations. As discussed in the following paragraph, further investigating including molecular experiments are required to dissect this complex pattern of association.

10.1371/journal.pone.0045863.t006

###### Haplotype effects derived from the rs317657 and rs11177644 at the 12q15 locus in the Gutenberg Health Study (N = 1,467).

![](pone.0045863.t006){#pone-0045863-t006-6}

  Polymorphisms                 Haplotype Frequencies       Haplotype effects on Gene Expressions[(1)](#nt110){ref-type="table-fn"}                                                                                                                                                         
  ------------------------ ------------------------------- ------------------------------------------------------------------------- ------------------------------ ------------------------------ ------------------------------ ------------------------------ -------------------------- --------------------------
  C                                       A                                                  0.399                                             reference                      reference                      reference                      reference                    reference                  reference
  C                                       G                                                  0.061                                     −0.231\[−0.271 -- −0.191\]     −0.209\[−0.246 -- −0.171\]      +0.067\[0.051 -- 0.083\]       +0.074\[0.051 -- 0.096\]     +0.082\[0.047 -- 0.117\]   +0.068\[0.041 -- 0.096\]
  T                                       A                                                  0.155                                     +0.018\[−0.008 -- 0.044\]      −0.073\[−0.103 -- −0.042\]      +0.051\[0.041 -- 0.061\]       +0.053\[0.041 -- 0.065\]     +0.058\[0.038 -- 0.078\]   +0.051\[0.035 -- 0.067\]
  T                                       G                                                  0.385                                     −0.258\[−0.277 -- −0.240\]     −0.281\[−0.301 -- −0.260\]      +0.061\[0.052 -- 0.070\]       +0.081\[0.068 -- 0.094\]     +0.079\[0.060 -- 0.098\]   +0.054\[0.038 -- 0.071\]
  Haplotypic association    R^2^ = 39.3%p = 1.72 10^−158^                        R^2^ = 36.6%p = 7.08 10^−145^                        R^2^ = 12.3%p = 2.52 10^−38^   R^2^ = 11.4%p = 1.00 10^−37^   R^2^ = 5.20%p = 3.02 10^−16^   R^2^ = 4.69%p = 2.55 10^−13^                             

  Polymorphisms                Haplotype Frequencies       Haplotype effects on Gene Expressions[(1)](#nt110){ref-type="table-fn"}                                                                                                                        
  ------------------------ ------------------------------ ------------------------------------------------------------------------- ------------------------------ ----------------------------- ----------------------------- -------------------------- --------------------------
  C                                      A                                                  0.399                                             reference                      reference                     reference                   reference                  reference
  C                                      G                                                  0.061                                     −0.083\[−0.120 -- −0.045\]     +0.017\[0.004 -- 0.029\]      +0.031\[0.011 -- 0.051\]     +0.022\[0.007 -- 0.037\]   +0.029\[0.002 -- 0.056\]
  T                                      A                                                  0.155                                     −0.033\[−0.056 -- −0.010\]     +0.019\[0.011 -- 0.027\]      +0.021\[0.007 -- 0.034\]     +0.021\[0.011 -- 0.030\]   +0.035\[0.020 -- 0.049\]
  T                                      G                                                  0.385                                     −0.086\[−0.108 -- −0.064\]     +0.023\[0.016 -- 0.031\]      +0.039\[0.028 -- 0.051\]     +0.024\[0.015 -- 0.033\]   +0.028\[0.014 -- 0.042\]
  Haplotypic association    R^2^ = 4.08%p = 8.30 10^−13^                        R^2^ = 3.31%p = 3.87 10^−10^                         R^2^ = 3.08%p = 6.70 10^−10^   R^2^ = 2.87%p = 3.40 10^−8^   R^2^ = 2.27%p = 2.21 10^−6^                             

Haplotype effects were estimated assuming haplotype additive effects after adjusting for age, gender, and *LYZ* and *YEATS4* expressions when appropriate.

After adjusting for rs317657, the rs11177644-G allele was associated with decreased *YEATS4* expression (β = −0.262, p = 1.36 10^−138^). After adjusting for rs11177644, the rs317657-T allele was no longer associated with *YEATS4* expression (β = −0.003, p = 0.748).

After adjusting for rs317657, the rs11177644-G allele was associated with decreased *LYZ* expression (β = −0.208, p = 9.56 10^−84^). After adjusting for rs11177644, the rs317657-T allele was associated with decreased *LYZ* expression (β = −0.072, p = 1.24 10^−10^).

Two interactions miSNPs × 3utrSNPs were robustly identified, the first involving *HLA-DPB1* rs1042448 and hsa-mir-219-1 rs107822, the second the *H1F0* rs1894644 and hsa-mir-659 rs5750504. In both cases, the identified 3\'UTR rare alleles were found to strongly increase the expression of the associated genes, but these over-expressions were highly reduced in carriers of miSNPs rare alleles. The identified miSNPs are not located within the mature sequence of the associated miRNAs but in their pri-miRNA sequences. These rare alleles could either be associated with increased miRNA expression or could tag for yet-unknown miSNPs within mature sequences leading to the production of isomiRs. It could be speculated that the associated miRNAs or isomiRs would then target the identified 3\'UTR regions made sensitive to miRNAs regulation by the identified 3\'UTR variants, variants that could create novel motifs for miRNAs\' binding and would lead to reduction of the *per se* effect of the 3\'UTR variant. Molecular constructs are required to assess such hypothesis. We further checked whether the identified miSNPs could interact with other 3\'UTR SNPs located in genes in the vicinity of the *HLA-DBP1* and *H1F0* loci. We did not observe any suggestive evidence (P\<0.05) for such interaction suggesting that the identified miRNA regulation would be specific to *HLA-DBP1* and *H1F0*.

The identified interactions involved SNPs in modest LD but located within a genomic distance of less than 100 kb. Several examples have already been observed where a given miRNA participates to the regulation of a gene located in its very close vicinity [@pone.0045863-Rodriguez1], [@pone.0045863-Kim1], [@pone.0045863-Inaoka1], [@pone.0045863-Inaoka2]. Nevertheless, one cannot exclude the possibility that the detected interactions are tagging for other complex haplotypic effects spanning a large distance and over several genes, five genes lying between *HLA-DPB1* and hsa-mir-219-1 and three between *H1F0* and hsa-mir-659 ([Figure 3](#pone-0045863-g003){ref-type="fig"}). Additional functional experiments would be required to biologically characterize the detected statistical interactions.

![Location of genes, miSNP and 3\'UTR SNPs at the two detected interacting loci.\
Gene are indicated as black rectangles with grey 3\'UTR. Bold red and blue SNPs represent miSNPs and 3utrSNPs respectively. Corresponding proxies are non-bold coloured. Top: *HLA-DBP1* locus on chromosome 6; Bottom: *H1F0* locus on chromosome 22.](pone.0045863.g003){#pone-0045863-g003}

Little is known about *H1F0* in human diseases except that it codes for a histone family member protein. Interestingly, hsa-mir-659 has been shown to influence the risk of dementia [@pone.0045863-Rademakers1] through a mechanism that could involve histone deacetylation [@pone.0045863-Fiesel1], [@pone.0045863-Fiesel2]. Although speculative, the joint contribution of *H1F0* and hsa-mir-659 on the risk of dementia could deserve further attention. Conversely the *HLA-DPB1* gene has been associated with several complex diseases such as pulmonary hypertension, hepatitis B infection and systemic sclerosis [@pone.0045863-Kamatani1]--[@pone.0045863-Zhou1]. In addition, hsa-mir-219-1 was suggested to play a role in schizophrenia and in N-methyl-D-aspartate (NMDA) glutamate receptor signaling, two pathophysiological mechanisms linked to *HLA-DPB1* [@pone.0045863-Verhelst1], [@pone.0045863-Zamani1] making our results of valuable information for scientists interested in these pathologies.

Several limitations of this work must be acknowledged. First, because our investigation was conducted on genotyped data of common SNPs, only 258 miRNAs were covered by our study, which represent less than one-quarter of the hypothesized total number of human miRNAs. Second, only one cell type was studied where not all genes are expressed. Therefore not all possible association could be explored. Third, expression were measured using the microarray technology that may be less efficient than emerging mRNA deep-sequencing methods for measuring, especially low abundant, mRNA levels [@pone.0045863-Sultan1], [@pone.0045863-Marioni1]. Because a given miRNA can bind several genes and a given 3\'UTR can be a target for several miRNAs, compensation phenomena are proposed to explain the relative low impact of miRNA regulation on mRNA expression generally observed [@pone.0045863-Huntzinger1]. Therefore, genetic effects associated with miRNA and 3\'UTR SNPs are hypothesized to be a modest size and very large sample size would be required to detect them. Despite having robustly identified two interactions, we cannot then exclude that other interactions with lower magnitude could have been missed due to power considerations, even if the two genome-wide expression datasets used in this work are among the largest collected so far in human epidemiological studies. Third, by discarding from our investigations probes harboring a SNP in their genomic sequence to avoid any bias in the results of the association analyses, some miRNA-sensitive regulatory mechanisms associated to genes tagged by probes matching their 3\'UTR region may have been missed. Last, our investigation was conducted in monocytes and results observed may not be portable to other cells or tissues.

Nevertheless, our study illustrates that the proposed strategy searching for interaction between miSNPs and 3\'UTR SNPs in genome-wide expression studies could be an alternative to bioinformatics prediction tools to identify miRNA targeted genes.

Materials and Methods {#s4}
=====================

Ethics Statement {#s4a}
----------------

This work was based on two genome-wide expression studies, the Gutenberg Health Study (GHS) for the discovery phase and the Cardiogenics Transcriptomic Study (CTS) for the replication stage. Both studies were approved by the Institutional Ethical Committee of each participating center and by the local and federal data safety commissioners (Ethik-Kommission der Landesärztekammer Rheinland-Pfalz) for GHS. These two studies have already been extensively described in [@pone.0045863-Castagne1]--[@pone.0045863-Zeller1] for GHS and in [@pone.0045863-Heinig1], [@pone.0045863-Shah1] for CTS.

Gutenberg Health Study {#s4b}
----------------------

This analysis was conducted in a population-based sample of 750 men and 717 women aged 35--74 years, of European descent. Monocytic RNA was isolated from peripheral blood monocytes by negative selection using RosetteSep Monocyte Enrichment Cocktail (StemCell Technologies, Vancouver, Canada), Trizol extraction and purification by silica-based columns. Expression profiles were assessed using the *Illumina* HT-12 v3 BeadChip (Illumina, CA, USA) with ∼48,000 probes covering 37,804 genes, and generated data were pre-processed using Beadstudio. Values from probes with ≤1 bead were re-imputed using SVD impute from the pcaMethods R package [@pone.0045863-Stacklies1]. Data were normalized using quantile normalization and VST transformation as implemented in the lumi R package. To avoid spurious associations due to hybridation difference, probes that contained SNPs or were not annotated to be of "*perfect*" quality according to ReMOAT [@pone.0045863-BarbosaMorais1] (Reannotation and Mapping of Oligonucleotide Arrays Technologies, <http://remoat.sysbiol.cam.ac.uk>) were discarded. Individuals were typed for genome-wide genotype data using the Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix, CA, USA). SNP analysis was restricted to autosomal SNPs with minor allele frequency \>0.01, call rate \>0.98 and Hardy-Weinberg equilibrium testing p-value \>10^−4^.

Cardiogenics Study {#s4c}
------------------

The present study included monocyte expression data from 758 individuals from European descent, 363 patients with coronary artery disease and 395 unrelated healthy individuals.

Monocyte RNAs were isolated from whole blood using CD14 micro beads (Miltenyi) and expression profile was processed in a single center using the *Illumina* HumanRef-8 v3 beadchip array (*Illumina* Inc., San Diego, CA) containing 24,516 probes corresponding to 18,311 distinct genes. After hybridization, array images were scanned using the *Illumina* BeadArray Reader and probe intensities were extracted using the Gene expression module (version 3.3.8) of the *Illumina BeadStudio* software (version 3.1.30). Raw intensities were processed in R statistical environment using the Lumi and beadarray packages. All array outliers were excluded and only arrays with high concordance in terms of gene expression measures (pairwise Spearman correlation coefficients within each cell type \>0.85) were included in the analyses.

Genomic DNA was extracted from peripheral blood leucocytes by standard procedures (Qiagen). Genome-wide genotyping was carried out using one of two *Illumina* arrays; the Sentrix Human Custom 1.2 M array and the Human 610 Quad Custom array. Data from the two arrays was combined as described in [@pone.0045863-Schunkert1]. SNP analysis was restricted to autosomal SNPs with minor allele frequency \>0.01, call rate \>0.95 and Hardy-Weinberg equilibrium testing p-value \>10^−5^.

Statistical analysis {#s4d}
--------------------

The association of miSNP proxies with probe expression was tested by use of a standard linear regression model under the assumption of additive allele effects (i.e. proxy genotype coded as 0/1/2 according the number of rare alleles). Pair-wise SNPs interactions on probe expression were tested using a standard linear regression model in which both SNP (miSNP and 3utrSNP) genotypes were coded as 0,1,2 together with the corresponding product term for interaction. All analyses were adjusted for age and gender, and additionally for disease status in CTS.

In the Gutenberg Health Study, a weighted-Bonferroni procedure was applied to identify genome-wide significant interactions. Each 3utrSNP was first assessed using the Levene statistic [@pone.0045863-Pare1] testing the equality of associated-probe expression variance across genotypes. The resulting log(p-value) was then used to weight the interaction p-value obtained from the linear regression analysis. This strategy is expected to be more powerful than a standard Bonferroni correction procedure [@pone.0045863-Benjamini1], [@pone.0045863-Dalmasso1] as it gives more weight to interaction involving probes showing higher differences in inter-genotype variance.

For each 3utrSNP *u* (*u* = 1 to N~utr~) associated with a Levene test p-value q*~u~*, we define a standardized weight *w~u~* as

such as where N~utr~, N~miSNP~, N are the total number of studied 3utrSNPs, miSNPs and interactions, respectively. Each interaction p-value P*~i~* is then weighted by the w*~u~* corresponding to the 3utrSNP that is involved in the interaction, leading to a weighted p-value P~i~\*. Each Pi\* that is then below 0.05/N is then declared genome-wide significant at the 0.05 type I error.

In Cardiogenics, the standard Bonferroni threshold was used to declare significance.

Identified interactions between pairs of SNPs were illustrated through haplotype analyses conducted by the THESIAS software implementing a Stochastic-EM algorithm for haplotype-based association analysis [@pone.0045863-Tregouet1]. All other statistical analyses were performed in R v. 2.12.0.

Supporting Information {#s5}
======================

###### 

**Genome-wide significant (p\<7.7 10^−9^) associations of miSNPs on monocyte gene expression in the Gutenberg Health Study.** ^(1)^ SNPs showing the strongest association (with P\<5 10^−5^) with gene expression within 1Mb of the associated probe. ^(2)^ Regression coefficient associated with the rare miSNP allele under an additive effect model, adjusted for age and gender. ^(3)^ P-value of the association between miSNP and gene expression. ^(4)^ P-value of the association between miSNP and gene expression adjusted for the best *cis* eSNP. ^(5)^ Pairwise r2 between miSNP and best *cis* eSNPs in GHS. ^(6)^ The best *cis* eSNP and the associated-miSNP coincide.

(XLSX)

###### 

Click here for additional data file.

###### 

***Cis*** **and** ***trans*** **-associations observed with the hsa-mir-1279 rs1463335^(1)^ separately in CAD patients and healthy subjects of the Cardiogenics Transcriptomic Study.** ^(1)^ The rs1463335 was tagged by the rs998022 in CTS. The rs146335 is located on chromosome 12, at position 69,667,075. As a consequence, the association observed with LYZ and YEATS4 are considered as *cis*-associations, the remaining eight as trans-associations. ^(2)^ Regression coefficient associated with the rare miSNP allele under an additive effect model, adjusted for age and gender. ^(3)^ P-value of the association between miSNP and gene expression.

(DOCX)

###### 

Click here for additional data file.

###### 

**Patterns of detected miSNPs × 3utrSNPs interaction separately in CAD and healthy subjects of the Cardiogenics Transcriptomic Study.** ^(1)^ Regression coefficient of the interaction term when both miSNP and 3utr proxy SNPs coded 0/1/2 according to the number of carried rare alleles are introduced in a linear regression model together with their interaction term. ^(2)^ P-value of the interaction test derived from the standard linear regression analysis in CTS. Bold p-values correspond to the detected interactions that were significant after Bonferroni correction in the whole CTS.

(DOCX)

###### 

Click here for additional data file.
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